Gilder Gagnon Howe & CO LLC Quanterix Corp Transaction History
Gilder Gagnon Howe & CO LLC
- $8.56 Billion
- Q4 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Quanterix Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 68,663 shares of QTRX stock, worth $518,405. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,663
Previous 472,280
85.46%
Holding current value
$518,405
Previous $6.12 Million
88.08%
% of portfolio
0.01%
Previous 0.08%
Shares
28 transactions
Others Institutions Holding QTRX
# of Institutions
163Shares Held
34.9MCall Options Held
121KPut Options Held
41K-
Ameriprise Financial Inc Minneapolis, MN3.21MShares$24.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$23.7 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA2.59MShares$19.5 Million2.08% of portfolio
-
Alliancebernstein L.P. New York, NY2.44MShares$18.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.22MShares$16.7 Million0.0% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $279M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...